Trade name/Generic name | Tepmetko Tablets 250 mg/Tepotinib Hydrochloride Hydrate | Crysvita Subcutaneous Injection 10 mg 1 mL/Burosumab (Genetical Recombination) |
---|---|---|
Drug price calculation method | Similar efficacy comparison method (I) | Cost accounting method (new) |
Price before adjustment (A) | 12,520.90 JPY | 155,774.00 JPY |
Premium for usefulness-based group (B) | 5 | 45 |
Premium for marketability-based group (C) | 0 | 10 |
Premium for Sakigake Designation Scheme (D) | 10 | 0 |
Addition factor*1 (E) | – | 1.0 |
Foreign average price adjustment*2 (F) | 1 | 1.26245 |
Calculation Formula | A × (1 + (B + C + D)/100) × F | A × (1 + (B + C + D)/100 × E) × F |
Price | 14,399.00 JPY | 304,818.00 JPY |